Search Results - "Grossi, Giancarlo"

Refine Results
  1. 1

    Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment by Frumento, Davide, Grossi, Giancarlo, Falesiedi, Marta, Musumeci, Francesca, Carbone, Anna, Schenone, Silvia

    “…In the last decade, many small molecules, usually characterized by heterocyclic scaffolds, have been designed and synthesized as tyrosine kinase inhibitors…”
    Get full text
    Journal Article
  2. 2

    Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma by Musumeci, Francesca, Cianciusi, Annarita, D'Agostino, Ilaria, Grossi, Giancarlo, Carbone, Anna, Schenone, Silvia

    Published in Molecules (Basel, Switzerland) (23-11-2021)
    “…In the last few years, small molecules endowed with different heterocyclic scaffolds have been developed as kinase inhibitors. Some of them are being tested at…”
    Get full text
    Journal Article
  3. 3

    Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus Agents by Giacchello, Ilaria, Musumeci, Francesca, D'Agostino, Ilaria, Greco, Chiara, Grossi, Giancarlo, Schenone, Silvia

    Published in Current medicinal chemistry (2021)
    “…Influenza is a seasonal disease that affects millions of people every year and has a significant economic impact. Vaccines are the best strategy to fight this…”
    Get more information
    Journal Article
  4. 4

    Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling by Grossi, Giancarlo, Scarano, Naomi, Musumeci, Francesca, Tonelli, Michele, Kanov, Evgeny, Carbone, Anna, Fossa, Paola, Gainetdinov, Raul R, Cichero, Elena, Schenone, Silvia

    Published in Molecules (Basel, Switzerland) (01-04-2024)
    “…The search for novel effective TAAR1 ligands continues to draw great attention due to the wide range of pharmacological applications related to TAAR1…”
    Get full text
    Journal Article
  5. 5

    An Update on JAK Inhibitors by Musumeci, Francesca, Greco, Chiara, Giacchello, Ilaria, Fallacara, Anna Lucia, Ibrahim, Munjed M, Grossi, Giancarlo, Brullo, Chiara, Schenone, Silvia

    Published in Current medicinal chemistry (01-01-2019)
    “…Janus kinases (JAKs) are a family of non-receptor tyrosine kinases, composed by four members, JAK1, JAK2, JAK3 and TYK2. JAKs are involved in different…”
    Get more information
    Journal Article
  6. 6

    Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors by Musumeci, Francesca, Sanna, Monica, Grossi, Giancarlo, Brullo, Chiara, Fallacara, Anna Lucia, Schenone, Silvia

    Published in Current medicinal chemistry (01-06-2017)
    “…The pyrrolo[2,3-d]pyrimidine nucleus is a deaza-isostere of adenine, the nitrogenous base of ATP, and is present in many ATP-competitive inhibitors of…”
    Get more information
    Journal Article
  7. 7

    Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells by Monteleone, Lorenzo, Marengo, Barbara, Musumeci, Francesca, Grossi, Giancarlo, Carbone, Anna, Valenti, Giulia E., Domenicotti, Cinzia, Schenone, Silvia

    Published in Pharmaceutics (01-07-2022)
    “…Glioblastoma (GBM) is the most common adult brain tumor and, although many efforts have been made to find valid therapies, the onset of resistance is the main…”
    Get full text
    Journal Article
  8. 8

    Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins by Di Braccio, Mario, Grossi, Giancarlo, Roma, Giorgio, Grazia Signorello, Maria, Leoncini, Giuliana

    Published in European journal of medicinal chemistry (01-05-2004)
    “…Pursuing our chemical and biological studies in this field, we described the multistep preparation of the new 5-, 6-, or 7-alkoxy and 7-alkoxy-8-methyl…”
    Get full text
    Journal Article
  9. 9

    Dreamlike Environments: “Story-living” in Virtual Reality Installations by Giancarlo Grossi

    Published in Cinergie (Online) (01-08-2021)
    “…This article examines the narrative identity of a new emerging medium, the virtual reality installation. In order to do so, the representation of dream states…”
    Get full text
    Journal Article
  10. 10

    Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia by Musumeci, Francesca, Greco, Chiara, Grossi, Giancarlo, Molinari, Alessio, Schenone, Silvia

    Published in Cancers (09-11-2018)
    “…Ponatinib is a third line drug for the treatment of chronic myeloid leukemia patients, especially those that develop the gatekeeper mutation T315I, which is…”
    Get full text
    Journal Article
  11. 11

    Pyrazole[3,4-d]pyrimidine derivatives loaded into halloysite as potential CDK inhibitors by Massaro, Marina, Barone, Giampaolo, Barra, Viviana, Cancemi, Patrizia, Di Leonardo, Aldo, Grossi, Giancarlo, Lo Celso, Fabrizio, Schenone, Silvia, Viseras Iborra, Cesar, Riela, Serena

    Published in International journal of pharmaceutics (15-04-2021)
    “…[Display omitted] •Nanocomposites based on HNTs/pyrazolo[3,4-d]pyrimidine derivatives were developed.•Kinetic release was performed in physiological pH…”
    Get full text
    Journal Article
  12. 12

    Introduction: the image between presence and absence by Grossi, Giancarlo, Pinotti, Andrea

    Published in AN-ICON (16-05-2022)
    “…Dream images, anticipations of the future, memories of the past, perceptual distortions, delusional hallucinations, cognitions intoxicated by alcohol and drugs…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Exploring An-Icons, Between Media Archaeology, Cultural History, Memory Studies and Contemporary Applications by Ilaria Ampollini, Fabrizia Bandi, Federica Cavaletti, Pietro Conte, Margherita Fontana, Giancarlo Grossi, Andrea Pinotti, Sofia Pirandello, Ilaria Terrenghi

    Published in Img journal (01-09-2024)
    “…The ERC Advanced Grant AN-ICON, coordinated by Andrea Pinotti and hosted by the Department of Philosophy Piero Martinetti of the University of Milan, is…”
    Get full text
    Journal Article
  16. 16

    Analogs, formulations and derivatives of imatinib: a patent review by Musumeci, Francesca, Schenone, Silvia, Grossi, Giancarlo, Brullo, Chiara, Sanna, Monica

    Published in Expert opinion on therapeutic patents (02-12-2015)
    “…The Bcr-Abl inhibitor imatinib was approved in 2001 for chronic myeloid leukemia therapy, and dramatically changed the lives of patients affected by this…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Introduzione. Fenomeni di generazione e media nell'età contemporanea by Giancarlo Grossi, Myriam Mereu

    Published in Schermi (Milano) (01-12-2019)
    “…Introduction to the special issue…”
    Get full text
    Journal Article